
Sam S. Chang MD, MBA
@urocancermd
Patricia and Rodes Hart Endowed Chair, Chief Surgical Officer, Vanderbilt Ingram Cancer Center
ID: 355233242
15-08-2011 01:38:26
1,1K Tweet
4,4K Followers
1,1K Following

Please join Vanderbilt Urology Urologic Oncology Society of Urologic Oncology Fellowship for Virtual Open House NEXT Tuesday! Learn about our high volume, opportunity-filled, collegial training program in the great city of #nashville YUO Link: redcap.vumc.org/surveys/?s=9WY…


Current options for BCG unresponsive #NMIBC. Eugene Pietzak Memorial Sloan Kettering Cancer Center joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss treatment options for BCG-unresponsive bladder cancer and the challenges of evaluating their comparative effectiveness. #WatchNow > bit.ly/3D5Ik2j


Urology showing up tonight to hustle for that muscle Barry's Nashville. Vanderbilt Urology Vanderbilt Pediatric Urology Sam S. Chang MD, MBA




Great visit from Jeffrey Holzbeierlein for the prestigious Donohue Visiting Professorship lecture series. Provided great insights into NMIBC and MIBC as well as leadership lessons. Indiana University Department of Urology IU Simon Comprehensive Cancer Center


Development and initial experience of a dedicated female #BladderCancer clinical care coordinator role. Presentation by Bree Duncan, RN, BSN Vanderbilt Health. #SESAUA25 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3FwI6m3 Southeastern Section



Neal Shore joins us to discuss the CREST trial of sasanlimab +/- BCG in high-risk NMIBC from the Amer. Urol. Assn. 2025 Annual Meeting. Stacy Loeb, MD Alexander Kutikov MD Todd 〽️ Morgan, MD Maria J. Ribal Quoc-Dien Trinh, MD, MBA Angie Smith Dave Penson Ashish M. Kamat, MD, MBBS Sam S. Chang MD, MBA Peter Black spotifycreators-web.app.link/e/FM23xO73SSb


All 💫 Rutgers Cancer Institute urologic oncology team Saum Ghodoussipour Vignesh Packiam, MD David Golombos Thomas Jang👇🏼Impactful work aimed to improve the lives and outcomes for our bladder cancer patients!! New York Section AUA Amer. Urol. Assn. YUO Society of Urologic Oncology IBCG Bladder Cancer Advocacy Network #AUA25 #UroSoMe

Congratulations to my dear friend, Ann Gormley, for her well deserved receipt of the prestigious Victor Politano award ! Dartmouth Urology Amer. Urol. Assn. SUFU #AUA2025


Highlights from #SUO24! Amy Luckenbaugh Vanderbilt Health & Sam S. Chang MD, MBA Vanderbilt Urology dive into late-breaking #bladdercancer trials—combo intravesical gem/BCG for BCG-exposed & phase III cretostimogene in BCG-unresponsive CIS. Key takeaway? More options than ever for #NMIBC, with


Thanks UroToday.com grateful to work w Sam S. Chang MD, MBA, future is bright for patients as we incorporate highly effective ADC/IO combinations, sensitive and predictive biomarkers, novel intravesical tx leading to bladder preservation for more patients Bladder Cancer Advocacy Network


Perioperative systemic therapies for muscle-invasive #BladderCancer. Jacqueline Brown, MD Winship Cancer Institute of Emory University joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss recent advances, including the #NIAGARA trial combining chemotherapy with durvalumab, and emerging data on antibody-drug conjugates

#BOND003 Cohort P results for BCG-unresponsive papillary bladder tumors. Mark Tyson Mayo Clinic joins Sam S. Chang MD, MBA Vanderbilt Urology discussing early results from BOND-003 Cohort P: 90.5% HG-RFS at 3 & 9 months with oncolytic immunotherapy cretostimogene. Well-tolerated & CIS-free
